Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Urologic Neoplasms 1Pleural Neoplasms 1Neurofibromatosis 2 1Carcinoma, Non-Small-Cell Lung 1

Interventions

HDAC-42 2Bevacizumab 2temsirolimus 1neratinib 1brigatinib 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Doxycycline 1Disulfides 1Crizotinib 1Cetuximab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 2 × Doxycycline × 1 year × Clear all
NCT05521048 2025-12-08

Doxycycline in Cutaneous Schwannoma (NF2)

Massachusetts Eye and Ear Infirmary

Phase 1/2 Active not recruiting
19 enrolled
CNS

Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡